A Randomized, Observer Blinded, Comparative, Phase I Safety Study in Two Age De-escalating Cohorts to Assess the Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2017
At a glance
- Drugs Typhoid vaccine Vi DT conjugate International Vaccine Institute/Incepta/SK Chemicals/PT Biofarma (Primary) ; Influenza virus vaccine; Pneumococcal vaccine conjugate; Typhoid vaccine Vi-polysaccharide
- Indications Typhoid
- Focus Adverse reactions
- Sponsors PT Bio Farma
- 12 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Sep 2017.
- 12 Jul 2017 Status changed from not yet recruiting to recruiting.
- 17 Apr 2017 New trial record